Preclinical development of a Nanopatch measles-rubella vaccine microarray patch (Bill & Melinda Gates Foundation grant administered by Vaxxas) (2017–2019)
- Grant type:
- Vaxxas Pty Ltd
- Researchers:
-
-
Professor, Research Development
Office of the Deputy Vice-Chancellor (Research and Innovation)Affiliate Professor
Australian Institute for Bioengineering and Nanotechnology
-
- Funded by:
- Vaxxas Pty Ltd
